Jakafi and Cleocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Jakafi (ruxolitinib phosphate) and Cleocin (clindamycin phosphate). Common drug interactions include anaemia among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Jakafi and Cleocin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Jakafi?

Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. eHealthMe is studying from 56,530 Jakafi users. Check the latest studies of Jakafi.

What is Cleocin?

Cleocin has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,940 Cleocin users. Check the latest studies of Cleocin.

On Aug, 09, 2026

12 people who take Jakafi and Cleocin together, and have interactions are studied.

What are the common drug interactions of Jakafi and Cleocin, by gender? *:

female:

Anaemia (lack of blood)
Dizziness
Fatigue (feeling of tiredness)
Haematocrit decreased
Hot flush (sudden feelings of heat)
Iron overload
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Red blood cell count decreased
White blood cell count decreased

male:

Cough
Disease progression
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Fatigue (feeling of tiredness)
Haemochromatosis (body to absorb more iron than usual from food)
Iron overload
Renal disorder (kidney disease)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Weight decreased

What are the common drug interactions of Jakafi and Cleocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaemia (lack of blood)
Dizziness
Fatigue (feeling of tiredness)
Haematocrit decreased
Hot flush (sudden feelings of heat)
Iron overload
Malaise (a feeling of general discomfort or uneasiness)
Memory impairment
Red blood cell count decreased
White blood cell count decreased

60+:

Cough
Disease progression
Pneumonia
Weight increased
Arthralgia (joint pain)
Joint crepitation
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Fatigue (feeling of tiredness)
Haemochromatosis (body to absorb more iron than usual from food)
Iron overload

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 25.00%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 2 people, 16.67%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 8.33%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 8.33%
Nausea And Vomiting: 1 person, 8.33%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Jakafi and Cleocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously